CoChat

A combined microfluidic-transcriptomic approach to characterize the extravasation potential of cancer cells

Open access
Bersini, Simone, Miermont, Agnes, Pavesi, Andrea, Kamm, Roger Dale, Thiery, Jean Paul, Moretti, Matteo, Adriani, Giulia · 2018 · Oncotarget
Cited by 38

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

// Simone Bersini 1, * , Agnes Miermont 2, * , Andrea Pavesi 3 , Roger Dale Kamm 2, 4 , Jean Paul Thiery 3, 5 , Matteo Moretti 1, 6, 7 and Giulia Adriani 2 1 Cell and Tissue Engineering Laboratory, Istituto Ortopedico Galeazzi, Milano, Italy 2 BioSystems and Micromechanics IRG, Singapore-MIT Alliance for Research and Technology, Singapore 3 Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore 4 Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA 5 Yong Loo Lin School of Medicine, Department of Biochemistry, National University of Singapore, Singapore 6 Regenerative Medicine Technologies Laboratory, Ente Ospedaliero Cantonale, Lugano, Switzerland 7 Swiss Institute for Regenerative Medicine, Lugano, Switzerland * These authors contributed equally to this work Correspondence to: Giulia Adriani, email: giulia.adriani@smart.mit.edu Matteo Moretti, email: matteo.moretti@grupposandonato.it Keywords: microfluidics; microarrays; cancer cell extravasation; tumor microenvironment; organ-specific metastasis Received: August 01, 2018 Accepted: October 25, 2018 Published: November 16, 2018 ABSTRACT The reciprocal interaction between circulating tumor cells (CTCs) and tissue-specific cells is influential for the progression of metastases. In particular, the process of extravasation relies on the complex cross-talk between cancer cells and other cellular players such as the endothelium and the secondary tissue. However, most in vitro studies only focus on one heterotypic cell-cell interaction and often lack of physiological relevance. In this project, we investigated both CTC-endothelium and CTC-secondary site interactions during cancer cell extravasation. We first used a microarray analysis of extravasated MDA-MB-231 breast cancer cells to identify key markers involved in extravasation. Then, we developed a tri-culture microfluidic platform combining cancer cells, endothelium and a bone-mimicking (BMi) microenvironment to assess how organ tropism influences the extravasation potential of cancer cells from different tissues. Through the microarray analyses of extravasated cancer cells we found that extravasation is associated with upregulation of late-metastatic markers along with specific proteases, such as matrix metalloprotease (MMP), a-disintegrin and metalloprotease (ADAM) and a-disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family members, which are all involved in endothelium glycocalyx shedding. Through the microfluidic extravasation assay, we found that the bone-like microenvironment increased invasion and motility of breast, bladder and ovarian cancer cell (MDA-MB-231, T24 and OVCAR-3). Among the three cell types, ovarian cancer cells presented the lowest migration rate and bladder cancer cells the highest, hence recapitulating their different level of bone tropism observed in vivo . Taken together, our results shed light on the importance of intercellular communication between CTCs and other non-tumor cells essential for promoting cancer cell extravasation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.26306

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

Metadata

Authors
Bersini, S., Miermont, A., Pavesi, A., Kamm, R. D., Thiery, J. P., Moretti, M., & Adriani, G.
Venue
Oncotarget
Published
2018-11-16
Volume
9
Issue
90
Pages
36110-36125
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2901902990
Cited by
38
References
9
FWCI
1.60
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.